An essential nutrient from animal foods or supplements, vital for blood, nerves, and cell function. In people who are genuinely low—often older adults, plant-based eaters, and users of certain stomach or diabetes medicines—correcting a shortfall reverses low blood counts, eases fatigue, and can repair nerve damage caught early. Well-nourished people gain little. Remarkably safe; test before supplementing. (Full Review)

Protocol

Oral Dose

1000–2000 mcg/day

Confirmed deficiency; cyano- or methylcobalamin

Injection

1000 mcg IM

Malabsorption: initial weeks, then every 1–3 months

Prevention

250–1000 mcg/day

At-risk groups, oral

Time to effect

Blood Counts

6–8 weeks

Reticulocytes respond within ~1 week

Nerve Recovery

Weeks–months

Depends on how early treatment begins

Homocysteine

Within weeks

Drops when combined with folate

Benefits

High: Corrects and prevents deficiency anemia; reverses and prevents deficiency-related nerve damage; lowers elevated homocysteine

Medium: Reduced fatigue and improved energy in deficiency; slowed brain atrophy in those with elevated homocysteine

Low: Adjunctive support for depressive symptoms; improved nerve outcomes in diabetes-associated deficiency

Speculative: Support of methylation and healthy aging; preservation of cognitive reserve at higher-than-minimal levels

Contraindications

Cobalamin/cobalt allergy (injectable form)

Leber hereditary optic neuropathy (cyanocobalamin)

Diabetic kidney disease (very high doses)

Unexplained very high serum B12 (evaluate first)

Key Interactions

Metformin (reduces absorption)

Proton pump inhibitors, H2 blockers (omeprazole, esomeprazole, ranitidine, famotidine)

Colchicine, chloramphenicol

High-dose vitamin C (separate timing)

High-dose folate (masks nerve damage)

Nitrous oxide (inactivates B12)

Risk & Side Effects

High: Acne-like skin eruptions; injection-site reactions and pain

Medium: Accelerated kidney function decline with high doses in diabetic kidney disease; hypokalemia and rebound effects when correcting severe anemia

Low: Allergic and anaphylactoid reactions to cobalamin injections; elevated serum B12 associated with higher mortality

Speculative: Possible lung cancer risk with long-term high-dose B6 plus B12 in male smokers; theoretical concerns with the cyanide moiety in cyanocobalamin

Monitoring

Marker	Target	Why
Serum Vitamin B12 (total)	>500 pg/mL	Screens for deficiency and over-repletion
Active-B12 (holotranscobalamin)	>70 pmol/L	Measures the fraction actually deliverable to cells
Methylmalonic Acid (MMA)	<270 nmol/L	Rises when B12 is functionally low inside cells
Homocysteine	<7–8 µmol/L	Rises with B12/folate insufficiency; vascular and brain-risk marker
Mean Corpuscular Volume (MCV)	85–90 fL	Enlarged red cells hint at deficiency
Serum Folate	>10 ng/mL	Interpreted together with B12

Cadence: Recheck at 8–12 weeks after starting or changing therapy, then every 6–12 months for maintenance.

Qualitative Assessment

Energy and reduced fatigue
Cognitive clarity, memory, and processing speed
Resolution of tingling, numbness, or balance issues
Mood stability
Glossitis (a sore, smooth tongue) or mouth-related symptoms clearing

Vitamin B12 for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment